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The methods used to screen prospective candidates for orthotopic liver transplantation are 
described. Both the indication and the contraindications for the procedure are discussed. The 
timing of the procedure during the course of an individual candidate's liver disease is also discussed. 
Additionally, the institutional requirements of a liver transplant center are identified. Finally, the 
problems experienced by a liver transplant patient and his physician during the postoperative 
period are identified and discussed. 
Orthotopic liver transplantation is becoming an in-
creasingly frequent, albeit still somewhat heroic, opera-
tive therapy for advanced irreversible chronic liver dis-
ease. During the decade from January, 1971 through 
December, 1980, a total of 192 such procedures were 
performed by Dr. Thomas E. Starzl at the University of 
Colorado (1). This figure averages out to approximately 
16 procedures being performed per year. During 1981, 
with Dr. Starzl in Pittsburgh, this figure doubled with a 
total of 34 operations being performed. In 1982, the 
number of such procedures performed increased further 
to an annual rate of 80. Moreover, during the first 4 
months of 1983, this accelerated rate of performance has 
continued with 27 procedures having been performed. 
Not only are those who have developed the procedure 
continuing to refine it and make it an acceptable thera-
peutic option for patients with advanced, otherwise hope-
less liver disease, but also other surgeons at distant 
institutions have either begun to develop their own ex-
perience or are in the process of planning to actively 
enter the field within the next year or two. 
The recent success achieved in improving the surgical 
mortality and the coincidental success of cyclosporin A 
as an immunosuppressant in improving the long-term 
prognosis for transplant patients has raised new chal-
lenges for the internist who also cares for these patients 
(2). Thus, the physician seeing patients with advanced 
liver disease is now faced with the following questions: 
(i) who should be transplanted? and (ii) conversely, who 
should not be transplanted? What are the options avail-
able for rejected patients? (iii) When should transplan-
tation be offered to a patient? (iv) What is the prognosis 
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for a given patient with a given disease process, such 
that an adequate decision concerning liver transplanta-
tion can be made? (v) What is the quality of one's life 
following successful transplantation? (vi) Are there any 
unique medical problems that develop or to which the 
patient is susceptible as a consequence of a successful 
liver transplant? 
The answers to these questions are the object of the 
following presentation. 
SELECTION OF THE TRANSPLANT 
CANDIDATE 
Several factors are mandatory accompaniments of can-
didacy for orthotopic liver transplantation (Table 1). 
These are first, that the individual under consideration 
indeed have an irreversible, chronic progressive liver 
disease. This necessitates that the specific disease pro-
cess dictating the procedure be identified, that its prog-
nosis be understood, and that either death or inevitable 
vegetative existence be the only alternatives to trans-
plantation. Second, and as a corollary to the first condi-
tion, the patient's liver disease should have progressed 
to a stage such that all other forms of therapy have 
already been exhausted (e.g., the disease condition must 
have reached the state of intractability). The third man-
datory requirement for candidacy is that the patient have 
no contraindications for orthotopic liver transplantation_ 
Contraindications to orthotopic liver transplantation 
can be divided readily into those that are absolute and 
those that are relative (Table 2)_ Assuming that the 
requirements for candidacy have been fulfilled, the ab-
solute contraindications for orthotopic liver transplan-
tation include portal vein thrombosis, such that the 
transplanted liver cannot be provided with the necessary 
portal venous vascular input with all of its contained 
nutrients, hormones, and hepatotrophic factors_ A sec-
ond contraindication is severe hypoxemia due to right to 
left intrapulmonary shunts with an arterial p02 <50 mm 
79S 
80S VAN THIEL ET AL. HEPATOLOGY 
TABLE 1. REQUIREMENTS FOR CANDIDACY 
Presence of a chronic irreversible and progressive liver disease 
Medical-surgical intractability 
No contraindications 
Ability to accept the procedure, understand its nature and/or costs 
TABLE 2. ABSOLUTE AND RELATIVE CONTRAINDICATIONS 
Absolute contraindications 
Portal vein thrombosis 
Severe hypoxemia due to right to left shunts 
Sepsis outside the hepatobiliary system 
Primary malignant disease outside the hepatobiliary system 
Metastatic hepatobiliary malignancy 
Active alcoholism 
Advanced cardiopulmonary or renal disease 
HBsAg- and HBeAg-positive state 
Age >55 years 
Inability to accept the procedure or understand its nature and/or 
costs 
Relative contraindications 
Intrahepatic or biliary sepsis 
Advanced alcoholic liver disease in the abstinent alcoholic 
Age >50 years 
HBsAg-positive state 
Prior abdominal surgery particularly in the right upper quadrant 
Hg. Such shunts occur in some patients with advanced 
liver disease and are thought to be a result of the liver 
disease rather than a primary cardiovascular or pulmo-
nary disorder. Despite such reasoning, we have found 
empirically that such shunts do not close postoperatively 
for periods of up to several weeks and that the resultant 
hypoxemia experienced postoperatively is yet another 
adverse factor that frequently turns a hopeful situation 
into a hopeless effort. Obviously, sepsis outside the hep-
atobiliary system is an absolute contraindication to 
transplantation as it consistently determines failure in 
the immediate perioperative period due to the require-
ment of intense immunosuppression during this same 
time period. Obviously, primary malignant disease out-
side the hepatobiliary system or metastatic hepatobiliary 
malignant disease is an absolute contraindication for 
surgery. In all such cases transplanted to date (inadvert-
ently because of failure to recognize such disease), the 
malignancy has had a markedly accelerated course post-
transplantation presumably as a result of the immuno-
suppression. Although active alcoholism is an absolute 
contraindication to hepatic transplantation, we have not 
categorically ruled out transplantation for this particular 
indication. Should the alcoholic have a verifiable or 
documented period of sobriety of 6 months or greater in 
duration, and successfully complete a preoperative eval-
uation, we would consider the alcoholic for transplanta-
tion. Even with such prerequisites, however, alcohol abu-
sers are not particularly good candidates. Not only are 
they always at risk to return to their prior alcoholism, 
but also their alcohol abuse frequently has injured not 
only the liver but also their lungs and other vital organ 
systems such that their ability to undergo liver trans-
plantation is effected adversely. 
In a similar vein, nonalcoholics with advanced cardio-
pulmonary or renal disease are also poor if not horrible 
candidates because their nonhepatic disease frequently 
is the factor that will determine their survival, not their 
liver disease. Individuals with viral-induced liver disease 
who are both HBsAg and HBeAg positive are at ex-
tremely high, if not prohibitive risk because of the uni-
versal risk of infection of the transplanted liver. More-
over, the immunosuppression required postoperatively 
appears to be a factor that accelerates the course of the 
viral infection in the transplanted liver, presumably by 
limiting the protective immune response of the recipient. 
Finally, the inability of the patient to either accept the 
procedure or to understand its nature and/or costs in 
terms of the need for life-long medical follow-up should 
be an absolute contraindication to its performance. Sim-
ilarly, patient age greater than 55 years (pragmatic upper 
limit) prohibits successful liver transplantation. 
Transplantation of patients with the former contrain-
dications will only lead to problems of recurrent or 
chronic rejection, inadequate or excessive immuno-
suppression, and probably recurrent sepsis in the post-
operative period. Thus, patients with the latter contrain-
dications usually are unable to withstand the rigors of 
the operation and postoperative period and frequently 
are likely to die as a result of some nonhepatic problem 
rather than their primary hepatobiliary disease. 
The relative contraindications to hepatic transplan-
tation include intrahepatic or biliary sepsis that cannot 
be resolved prior to transplantation. Although such prob-
lems may be the same factors that are necessitating the 
procedure, they act also to increase the risk of death 
following transplantation and therefore, such patients 
have to be carefully evaluated and screened prior to such 
surgery. As discussed above, the many nonhepatic prob-
lems associated with alcohol abuse and present in the 
abstinent alcoholic make such patients poor risks for the 
procedure. 
Hepatitis B antigenemia in the absence of HBeAg 
positivity is a relative rather than an absolute contrain-
dication for hepatic transplantation. Such individuals 
may not always infect the donor liver and therefore can 
be considered high risk, albeit not unreasonable, candi-
dates for the procedure. 
Finally, advanced renal disease may be a relative con-
traindication as both cyclosporin A therapy, and the 
surgical procedure itself is capable of worsening renal 
function, at least temporarily. This latter contraindica-
tion may be less of a problem with a larger experience, 
and of course, may be remedied with either dialysis or 
renal transplantation. 
TIMING OF THE PROCEDURE 
The second major question the internist has to ask 
concerning liver transplantation is when should the pro-
cedure be performed, once an acceptable candidate has 
been identified. This, like the former question, is difficult 
to answer specifically, but some common sense guidelines 
can be identified (Table 3). Obviously, the procedure 
should be performed prior to the development or acqui-
sition of any of the absolute contraindications identified 
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TABLE 8. WHEN SHOULD LIVER TRANSPLANTATION BE OFFERED? 
General !!:lJidelines applicable to all disease states 
1. prior to the development of any of the absolute contraindications 
for hepatic transplantation 
2. prior to irreversible extrahepatic deterioration occurring as a 
consequence of the primary liver disease. 
Disease specific indications 
1. Chronic liver disease 
(a) prior to preterminal variceal bleeding 
(b) prior to the irreversible hepatorenal syndrome 
(c) prior to the development of catabolic state inconsistent with 
surgical survival 
(d) prior to irreversible brain injury occurring as a consequence 
of or as a part of hepatic encephalopathy 
(e) bilirubin levels >20 mg/dl 
(f) albumin level <1.8 gm/dl 
(g) prior to the development of an uncorrectable coagulopathy 
I h) prior to the onset of vascular instability associated with 
anasarca, ascites. and pleural effusions 
(i) prior to irreversible metabolic bone injury associated with the 
primary liver disease 
2. Subacute liver disease 
(a) bilirubin >25 mg/dl 
(b) factors a, b, c. g. h listed above for chronic liver disease 
3. Acute or fulminant liver disease 
(a) only it· patient al site capable oftransplantation at recognition 
(b) fulminant form of Wilson's disease 
in Table 1. Moreover, the relative contraindications 
should also be kept at an absolute minimum or not be 
present as problems. In addition, the procedure cannot 
be offered to someone who has progressed to a stage in 
the course of their liver disease at which an irreversible 
extrahepatic complication such as brain injury, sponta-
neous consumption coagulopathy, or vasomotor instabil-
ity is present. 
In general, when one or another of the following pa-
rameters is present, liver transplantation is indicated: 
bilirubin exceeding 20 mg per dl; albumin below 1.8 gm 
per dl; encephalopathy unresponsive to the combination 
of a low protein diet «40 gm per day), lactulose and 
neomycin. In addition, should a physician be contem-
plating portal caval shunting, or any of a variety of other 
portal decompressive procedures, liver transplantation 
should become an alternative option. With the former 
procedures, the patient's encephalopathy may worsen 
with either unaltered or worsened hepatic disease, while 
with the latter procedure (transplantation) both the por-
tal hypertension and the primary liver disease are re-
solved. 
With fulminant hepatic failure, be it due either to 
drugs, toxins, or viral injury, transplantation remains a 
therapeutic option; however, because of the precarious 
condition of these patients, it can only be offered to those 
who progress to Stage 3 or Stage 4 coma at the institution 
where liver transplantation is being performed. In our 
experience, patients with a fulminant hepatic failure in 
Stage 3 or Stage 4 encephalopathy cannot be safely 
transferred to a transplantation center with any degree 
of certainty. The majority that we have accepted for 
transplantation with this indication have experienced 
brain stem herniation or intracerebral hemorrhage en-
route to our institution or soon after their arrival, making 
the procedure untenable and consuming valuable re-
sources and manpower that otherwise would have been 
used for transplantation. 
WHERE SHOULD PROCEDURE BE 
PERFORMED? 
Numerous institutions are beginning to embark in the 
broad area or organ transplantation. Many of these in-
stitutions are planning to include liver transplantation 
as a component of their overall transplantation experi-
ence. Such a plan is both wise and cost-effective as many 
of the skills and facilities of a transplantation program 
are directly applicable to liver as well as other organ 
transplantation programs. The minimal obligatory re-
quirements of a liver transplantation centers are identi-
fied in Table 4. In addition, useful, but not absolutely 
necessary other services that should be included in the 
development of a transplantation program are identified 
also in the table. 
Any institution that has made a commitment to fulfill 
these requirements can legitimately enter the field. 
Moreover, each such institution should be encouraged to 
do so, as the number of acceptable candidates for trans-
plantation and the number of available donor organs far 
exceed the capabilities of the few centers presently per-
forming the procedure. When more centers begin to offer 
the procedure, regional resources and facilities could be 
used to better advantage and at lower costs, in terms of 
patients lost while waiting for the procedure, wastage of 
valuable donor organs, and dollars and time spent in 
caring for such patients. 
With more centers performing the procedure, fewer 
patients should die as a result of progressive deterioration 
while waiting for surgery. In support of this latter state-
ment, at our institution during the last 2 years, twice as 
many patients have died waiting for liver transplantation 
once they have been accepted as transplant candidates 
TABLE 4. INSTITUTIONAL REQUIREMENTS OF A SUCCESSFUL LIVER 
TRANSPLANT PROGRAM 
I. Obligatory requirements 
(a) surgeons capable of and willing to perform the procedure 
(b) hepatologists capable of caring for and identifying candidates 
who have a working relationship with the operating surgeons 
(c) an active renal dialysis program capable of providing the renal 
support required by such patients and the program 
(d) adequate intensive care and operating room facilities and staff 
capable of accommodating the surgery when donor organs 
become available 
(e) an active infectious disease program capable of recognizing and 
identifying unusual viral, fungal, and protozoal infections 
(f) a blood bank capable of providing the necessary blood and 
blood products on demand often with little or no advanced 
warning of need 
II. Useful programs 
(a) psychiatric service for patients and families 
(b) an active immunology transplantation program 
(c) broad-based community support for the program to include 
housing for patients and their families 
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than those who have died having once been operated 
upon. 
Similarly, as can be seen in Table 5, many donor organs 
have not been used because of surgical team fatigue, 
unavailability of surgeons, anesthesiologists, intensive 
care unit space or operative room facilities, or lack of an 
appropriate recipient for the donor organ presently avail-
able. 
Equally important to actually having both the medical 
and surgical expertise to perform the surgery and to care 
for the patient pre- and postoperatively at a given insti-
tution, is the successful interaction between these serv-
ices. This requirement is often overlooked and neglected 
but is of paramount importance if a program is to be 
successful. Moreover, a common goal and commitment 
by both services involved is readily recognized by patients 
and their families and greatly facilitates the care and 
education of such patients both before and after the 
surgery. 
AFTER THE OPERATION 
The medical physician's responsibilities do not dissi-
pate with the performance of the procedure. Instead, 
they shift their emphasis (Table 6). Their intensity, 
however, remains unchanged. Prerenal azotemia and 
acute tubular necrosis complicated further by antibiotic-
induced renal disease and the administration of cyclos-
porin A are almost universal concomitants of the post-
operative period. Similarly, careful attention to pulmo-
nary and cardiovascular problems occurring as a conse-
quence of massive shifts in body fluids occurring during 
and following the operation is a mandatory obligation 
during the perioperative period. Such acute postoperative 
responsibilities are quickly replaced by concerns about 
rejection, (its recognition and management), infection, 
(its recognition and control), the possibility of recurrent 
or new (transplant-associated) forms of liver disease, and 
the psychosocial adjustments that occur with successful 
rehabilitation. 
Differentiation of a rejection episode from new or 
recurrent hepatic injury is difficult if not impossible. All 
manners of presentation have been seen with rejection 
TABLE 5. LIVER DONOR REFERRALS AND DISPOSITION OTHER THAN 
FOR TRANSPLANTATION 
Liver donor referrals 523 
Disposition of donor referrals 
Declined: concurrent donor 74 
Declined: surgical team busy in OR 12 
Declined: surgical team unavailable 39 
Declined: surgical team exhausted/understaffed 51 
Declined: OR/anesthesia is unavailable 4 
Declined: no ICU beds 43 
Declined: donor clinically unsuitable 49 
Declined: unacceptable donor age 34 
Declined: no compatible recipient 85 
Declined: donor center too distant 3 
Donor family refused 35 
Local M.D. or medical examiner refused 3 
Donor experienced cardiopulmonary arrest prior to organ 6 
recovery 
Recipient expired prior to transplantation 5 
Livers recovered and transplanted 80 
TABLE 6. POSTOPERATIVE PROBLEMS IN LIVER TRANSPLANTATION 
PATIENTS 
I. Renal dysfunction 
(a) Cyclosporin injury 
(b) Tubular necrosis due to hypoperfusion 
(c) Antibiotic injury 
II. Rejection crisis 




IV. Graft vascular injury 
(a) Hepatic vein obstruction 
(b) Hepatic artery thrombosis/stenosis 
(c) Portal vein thrombosis/stenosis 
V. Infections (bacterial and viral, fungal) 
(a) Abdominal-perihepatic abscess 
(b) Biliary tree 
(c) Pulmonary 
(d) Reactivated virus 
(e) Gastrointestinal tract 
(f) Catheter associated (intravenous, urinary tract, and endotra-
cheal) 
including evidence for hepatocellular, cholestatic, or 
mixed hepatocellular-cholestatic syndromes. The param-
eters which have proved to be the most useful in the 
recognition of a rejection episode and in clinical manage-
ment of patients during this period include the serum 
bilirubin level, the alkaline phosphatase level, efforts at 
visualization of the biliary tree, and identification of 
fluid collections (abscesses) in and about the operative 
field. Injury to the hepatic artery, portal vein or vena 
cava, or biliary tree occurring at time of surgery may go 
unrecognized at operation or be occult until several days 
or weeks have elapsed since the operation. Changes in 
the size and/or consistency of the transplanted liver, as 
determined by repeated careful physical examinations, 
are excellent indicators of such untoward events. Any 
increase in liver size or consistency must alert the phy-
sician to the possibility of either a rejection crisis or the 
development of a vascular injury and should suggest 
other studies. An increase in either the serum bilirubin 
level or in alkaline phosphatase activity should suggest 
the possibility of a biliary tract problem (leak or stenosis) 
or rejection. The latter condition may be resolved with 
the techniques of ultrasonography, T-tube, or percuta-
neous transhepatic cholangiography. Vascular problems 
are best evaluated with angiographic studies and liver 
spleen scanning techniques. Unfortunately, organ rejec-
tion must remain a diagnosis of exclusion. 
Liver biopsy, particularly when it suggests another 
mechanism for the observed postoperative hepatic injury, 
helps on occasion in resolving this difficult differential 
problem. Unfortunately, it has not proven to be of con-
sistent help in establishing the specific diagnosis of re-
jection. Fine intralobular hepatocellular regeneration, 
centrilobular bland hepatocellular necrosis, and a paucity 
of bile ducts are occasionally seen and should suggest 
rejection, although they are not entirely specific. Even 
when sophisticated techniques of lymphocyte subtyping 
and enumeration have been utilized, the diagnosis of 
rejection has not been an easy one to establish with liver 
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biopsy. Both T and B lymphocytes can he seen in reject-
ing livers but no specific pattern of such cellular infil-
trates has been recognized (3). Moreover it appears, 
based upon limited and to date rather anecdotal experi-
ence, that liver biopsy is more dangerous in patients 
posttransplantation than it is in other clinical situations. 
This increased risk appears to he the result of a greater 
incidence of postbiopsy bleeding, presumably due to the 
hypervascularity of the transplanted liver. 
Finally, infections in and about the operative site 
involving the liver, biliary tree, and lung are common 
and must be carefully watched for, recognized, and 
treated when found. With long hospitalization in the 
surgical intensive care unit, nosocomial pulmonary in-
fections and fungal infections of the upper gastrointes-
tinal tract are common and may prove to be difficult 
additional problems with which the physician has to 
reckon. Thus, 44 % of our patients have had fungal infec-
tions of which 16% have had fungemia (4). Candida 
infections have been the most frequent, but in addition 
aspergillosis, mucor, and cryptococcal infections have 
occurred. Viral infections of the herpes group (cytome-
galovirus, herpes simplex virus, herpes zoster virus, and 
Epstein-Barr virus) are particularly common after liver 
transplantation. Cytomegalovirus reactivation or new 
infection has been almost universal and is followed in 
order by herpes simplex virus and Epstein-Barr virus 
infections. 
Despite the numerous difficulties with patient selec-
tion, preparation, and postoperative care experienced in 
clinical liver transplantation and enumerated above, the 
overall success and improvement in patient status follow-
ing successful procedures is of such magnitude that it is 
indeed a reasonable and worthwhile endeavor. Specifi-
cally in terms of psychiatric status, social and behavioral 
functioning and intelligence, patients surviving liver 
transplantation do not differ from levels defining the 
normal population (5). Thus, compared to their pretrans-
plant state, they are remarkably improved and effectively 
have been transferred from a population of chronically 
ill hospital-bound patients to that of normal working 
individuals who are capable of enjoying and contributing 
to their own life and to society at large. 
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